+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06774690

Observational Study on Intra-Arterial Therapies for Primary Liver Cancer Including Hepatocellular and Cholangiocarcinoma

Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-14

3300

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to identify the best conditions for positive outcomes in men and women undergoing intra arterial therapy IAT for primary liver cancer, including hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Intra arterial therapies are radiological procedures that block the blood supply to liver tumors. The study is observational, combining both retrospective and prospective data collected at a single hospital to analyze clinic and radiological factors influencing treatment response. The study involves analyzing data from patients who have received or will receive intra arterial therapies such as trans-arterial embolization TAE, transarterial chemoembolization TACE, transarterial radioembolization TARE, and drug-eluting beads chemoembolization DEB-TACE. Retrospective data from patients treated since January 2009 will be reviewed, while prospective participants will be followed for 5 years with regular follow-up every three months. All therapies are performed within routine clinical care without additional experimental drugs. Participants will have their radiological images like CT scans and MRIs examined to assess tumor type, size, and response to treatment, as well as to monitor for possible complications. Researchers will measure outcomes including the size and type of liver injury, radiological response, and post-treatment complications over a period of up to 9 years. The study involves ongoing follow-up visits to track these outcomes and collect clinical information during the study period.

CONDITIONS

Brief Title

Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study

Research Team

C

Cristina Mosconi, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here